Company updates

Diag-Nose.io Establishes New State-of-the-Art Lab at CoLabs Notting Hill

A new space to support our commitment to driving innovation in precision respiratory medicine.

Read more  ->

Press releases

Diag-Nose.io Closes Oversubscribed $3.15M Seed Round to Revolutionise Respiratory Care with AI-Driven Precision

January 29, 2025

Diag-Nose.io Secures $50,000 Grant to Revolutionise Respiratory Care

August 19, 2024

Diag-Nose.io Announced as Australia's First HealthTech Startup to Graduate From Prestigious Global Creative Destruction Lab (CDL) Program, Bringing Their World-First Precision Medicine Tool For Managing Chronic Respiratory Disease Closer to Reality

June 28, 2023

Blog

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Company updates

Diag-Nose.io Establishes New State-of-the-Art Lab at CoLabs Notting Hill

January 20, 2025
Company updates

Green Light from Bellberry to Commence ENBOARD Clinical Study

November 25, 2024
Company updates

Diag-Nose.io Showcases Nasal Microsampling Research at ABNA Biobanking Conference

October 16, 2024

Publications

No items found.

Join our mission to eliminate respiratory disease

Reach out today to learn how you can help make a difference.

Get in touch
Pages
PeopleProductsProgramsPurposeMediaCareers
Contact us
Info@diag-nose.io
Socials
LinkediNInstagramX / TWITTERFacebook